Compass Pathways Prepares for Psilocybin Therapy Launch Next Year
Compass Pathways is preparing to finalize its regulatory submission for COMP360, a synthetic psilocybin treatment for treatment-resistant depression, with a potential market launch early next year. CEO Kabir Nath stated … Read More